Page last updated: 2024-08-20

dydrogesterone and Flushing

dydrogesterone has been researched along with Flushing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dain, MP; MacCarthy, K; Studd, JW; Zamblera, D	1

Trials

1 trial(s) available for dydrogesterone and Flushing

Article	Year
Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy study. Scandinavian journal of rheumatology. Supplement, 1996, Volume: 103 Topics: Bone Density; Double-Blind Method; Dydrogesterone; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Humans; Menopause; Osteoporosis, Postmenopausal; Pilot Projects	1996

Article

Year

Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy study.

Scandinavian journal of rheumatology. Supplement, 1996, Volume: 103

Topics: Bone Density; Double-Blind Method; Dydrogesterone; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Humans; Menopause; Osteoporosis, Postmenopausal; Pilot Projects

1996